We are live on ! Find out more
TC

Torno Capital Portfolio holdings

AUM $725M
1-Year Est. Return 62.71%
This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+62.71%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.14B
AUM Growth
+$581M
Cap. Flow
+$430M
Cap. Flow %
20.08%
Top 10 Hldgs %
59.87%
Holding
369
New
112
Increased
19
Reduced
36
Closed
191

Sector Composition

1 Technology 18.94%
2 Communication Services 11.2%
3 Consumer Discretionary 9.29%
4 Healthcare 3.47%
5 Consumer Staples 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
X
101
PUT
DELISTED
US Steel
X
$907K 0.04%
24,000
-10,000
-29% -$382K
HD icon
102
CALL
Home Depot
HD
$346B
$895K 0.04%
+2,600
New +$887K
AMT icon
103
PUT
American Tower
AMT
$79.5B
$875K 0.04%
+4,500
New +$841K
BRK.B icon
104
Berkshire Hathaway Class B
BRK.B
$1.07T
$814K 0.04%
2,000
-65,000
-97% -$26.6M
AMBA icon
105
Ambarella
AMBA
$2.64B
$809K 0.04%
+15,000
New +$745K
NVS icon
106
Novartis
NVS
$294B
$798K 0.04%
+7,500
New +$753K
SBUX icon
107
CALL
Starbucks
SBUX
$122B
$786K 0.04%
+10,100
New +$823K
CAG icon
108
CALL
Conagra Brands
CAG
$6.97B
$779K 0.04%
27,400
-436,300
-94% -$13.1M
NKE icon
109
CALL
Nike
NKE
$65.5B
$754K 0.04%
+10,000
New +$929K
INSM icon
110
CALL
Insmed
INSM
$23.5B
$710K 0.03%
10,600
+4,200
+66% +$163K
RF icon
111
CALL
Regions Financial
RF
$27.4B
$601K 0.03%
30,000
-2,700
-8% -$52.4K
CTLT
112
CALL
DELISTED
CATALENT, INC.
CTLT
$562K 0.03%
10,000
CTLT
113
PUT
DELISTED
CATALENT, INC.
CTLT
$562K 0.03%
10,000
EXEL icon
114
Exelixis
EXEL
$14B
$562K 0.03%
+25,000
New +$555K
AVPT icon
115
PUT
AvePoint
AVPT
$2.78B
$521K 0.02%
50,000
+48,100
+2,532% +$417K
IMCR icon
116
PUT
Immunocore
IMCR
$1.79B
$508K 0.02%
+15,000
New +$765K
NFE icon
117
CALL
New Fortress Energy
NFE
$95.1M
$506K 0.02%
+23,000
New +$594K
PRIM icon
118
PUT
Primoris Services
PRIM
$4.72B
$499K 0.02%
+10,000
New +$495K
QGEN icon
119
CALL
Qiagen
QGEN
$8.49B
$497K 0.02%
11,764
-48,611
-81% -$2.13M
SBH icon
120
CALL
Sally Beauty Holdings
SBH
$1.43B
$461K 0.02%
43,000
MLTX icon
121
CALL
MoonLake Immunotherapeutics
MLTX
$1.64B
$440K 0.02%
10,000
-5,000
-33% -$212K
ELAN icon
122
PUT
Elanco Animal Health
ELAN
$13B
$427K 0.02%
+29,600
New +$473K
DAWN
123
CALL
DELISTED
Day One Biopharmaceuticals
DAWN
$413K 0.02%
+30,000
New +$439K
DAWN
124
PUT
DELISTED
Day One Biopharmaceuticals
DAWN
$413K 0.02%
+30,000
New +$439K
CALX icon
125
Calix
CALX
$2.47B
$410K 0.02%
+11,575
New +$373K

Similar funds

Torno Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Torno Capital held 369 positions worth $2.14B, up 37% from $1.56B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Torno Capital deployed $430M of net new capital in Q2 2024, opening 112 new positions and adding to 19 existing holdings. Its largest new stake was Amazon: 996,640 shares worth $193M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 7.2% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $114M trimmed.

  • Torno Capital's largest Q2 2024 buy was Amazon: 996,640 shares worth $193M.
  • Torno Capital added most to Regeneron Pharmaceuticals in Q2 2024, an estimated $13.9M increase.
  • Torno Capital's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $114M.
  • Torno Capital fully exited Booking.com in Q2 2024, selling an estimated $81.6M.
  • Torno Capital's ten largest holdings make up 60% of its $2.14B portfolio in Q2 2024.
  • Torno Capital opened 112 new positions and closed 191 in Q2 2024.
  • Torno Capital's portfolio value rose 37% quarter-over-quarter to $2.14B.

Based on Torno Capital's 13F filing for Q2 2024, filed 14 Aug 2024.